Molecular Aberrations Are Still Present After Ablative Therapy of Barrett's Esophagus

Genomic analysis of Barrett's esophagus

Genomic analysis of Barrett's esophagus after ablative therapy: Persistence of genetic alterations at tumor suppressor loci

✍ Mariska Hage; Peter D. Siersema; Kees J. Vissers; Winand N.M. Dinjens; Ewout W. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 163 KB

## Abstract Barrett's esophagus (BE) is a major predisposing factor for the development of esophageal adenocarcinoma. Current strategies for treatment of BE, both dysplastic and nondysplastic, include photodynamic therapy (PDT) and argon plasma coagulation (APC). However, the effect of ablative the